Latest Zotarolimus Stories
LONDON, Nov. 11, 2014 /PRNewswire/ -- REPORT DESCRIPTIONGlobal Market Watch:Global Coronary Stents sector is projected to reach US$9.5 billion by 2016.
A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention (PCI).
Transparency Market Research published new "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)" market research report to its report store.
Transparency Market Research Published new "Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)" market research report to its report store.
A study found that second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions.
WATFORD, England, September 7, 2010 /PRNewswire-FirstCall/ -- - Resolute Integrity Stent Launched in the UK Medtronic, Inc.
STOCKHOLM, September 2, 2010 /PRNewswire/ -- - Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions Three new analyses of subgroups from the SORT OUT III study presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden, provide additional detail on longer-term follow-up subgroup safety and efficacy outcomes in the SORT...